A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity. (2020)

First Author: Koch K
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41420-020-0258-3

PubMed Identifier: 32337072

Publication URI: http://europepmc.org/abstract/MED/32337072

Type: Journal Article/Review

Volume: 6

Parent Publication: Cell death discovery

ISSN: 2058-7716